The current paradigm for biologic initiation: a mixed-methods exploration of practices, unmet needs, and innovation opportunities in self-injection training-Reference-Cited by-同舟云学术

The current paradigm for biologic initiation: a mixed-methods exploration of practices, unmet needs, and innovation opportunities in self-injection training

Published:2021-06-08 Issue:8 Volume:18 Page:1151-1168
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Rinaldi Amy¹,Katsaros Dimos¹²,Hawthorne James¹²,D’Auria Matthew¹,Brigham Katherine¹,Bajars Erika¹,Franzese Chris¹²^ORCID,Coyne Marty¹²^ORCID

Affiliation:

1. Matchstick LLC, Boonton, NJ, USA

2. College of Pharmacy, University of Rhode Island, Kingston, RI, USA

Funder

Noble

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2021.1912009

Reference61 articles.

1. Is My Patient Overwhelmed?

2. Does route of administration affect the outcome of TNF antagonist therapy?

3. Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability

4. The Injection Technique Factor: What You Don’t Know or Teach Can Make a Difference

5. Examining the Influence of Behavioral Factors on Compliance and Persistence with Glatiramer Acetate Injection for Relapsing-Remitting Multiple Sclerosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design;Advanced Drug Delivery Reviews;2024-06

2. The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices;Expert Opinion on Drug Delivery;2022-05-27